BDBM224286 3-(6-{[(1r)-1- cyclobutylethyl]amino}-7-[1-(trans- 4-methylcyclohexyl)ethyl]-8-[(3r)- 3-methylmorpholin-4-yl]-7h-purin- 2-yl)-1,2,4-oxadiazol-5(4h)-one (diastereomer a)::US9540377, 18.12::US9540377, 18.13

SMILES CC([C@H]1CC[C@H](C)CC1)n1c(N2CCOC[C@H]2C)nc2nc(-c3noc(=O)[nH]3)nc(N[C@H](C)C3CCC3)c21

InChI Key InChIKey=IGGZZTLQCKAKPW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 224286   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224286BDBM224286(US9540377, 18.12 | US9540377, 18.13 | 3-(6-{[(1r)-...)
Affinity DataIC50: 2.27nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224286BDBM224286(US9540377, 18.12 | US9540377, 18.13 | 3-(6-{[(1r)-...)
Affinity DataIC50: 2.82nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent